We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

AnPac Bio-Medical Science Co Ltd (ANPC) ADS EACH REPR 1 ORD SHS SPON

Sell:$0.68 Buy:$0.70 Change: $0.0391 (5.44%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$0.68
Buy:$0.70
Change: $0.0391 (5.44%)
Deal now Deal for just £11.95 per trade in a SIPP or Fund and Share Account
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$0.68
Buy:$0.70
Change: $0.0391 (5.44%)
Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a SIPP or Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

AnPac Bio-Medical Science Co., Ltd. is a China-based biotechnology company focused on early cancer screening and detection. The Company markets and sells multi-cancer screening and detection test that uses cancer differentiation analysis (CDA), technology and its cancer-detection device or CDA device. In addition to early cancer screening and detection, its CDA technology assists physicians in cancer diagnosis, prognosis and recurrence. Its CDA technology provides a platform on which it has developed cancer screening and detection test using its CDA technology, or CDA test, and its CDA device. Its CDA technology focuses on biophysical properties in human blood. The Company have established two clinical laboratories in China and one clinical laboratory in the United States.

Contact details

Address:
801 Bixing Street, Bihu County
Lishui
F4 323006
China
Telephone:
+86 (578) 20516666
Website:
www.anpac.cn/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ANPC
ISIN:
US03635R1077
Market cap:
$14.92 million
Shares in issue:
17.77 million
Sector:
Biotechnology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Chang Yu
    Chairman of the Board, Chief Executive Officer, Founder
  • Herbert Yu
    Co-Founder, Chief Medical officer
  • Jinqiu Tang
    Chief Financial Officer
  • Weidong Dai
    President, China
  • Sunil Pandit
    Chief Executive Officer - United States
  • Xuedong Du
    Vice President - Research & Development

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a SIPP or Fund and Share Account

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.